Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

2TrustHim Jun. 5 at 4:43 AM

$SINT so when this all clears up where the price go

0 · Reply

Boston7452 Jun. 5 at 1:44 AM

$SINT I say Medtech should lead the way in removing mgmt/board but in all honesty there’s little chance Medtech wasn’t aware of at least some of the stuff concerning Ned Medical. I’d like to know who all participated in their Jan raise? I wouldn’t be surprised if some of the investment money came from money connected to Sintx.

0 · Reply

Boston7452 Jun. 4 at 8:06 PM

$SINT Varian, a subsidary of Siemens, represents a MAJOR validation for Ned Medicals and Sintx technology. This should have shot the stock upward a fair bit. But instead Sintx mgmt seems to have conspired to give Ned Medical the technology and issue a crap ton of shares and warrants with the warrants encouraging shorting with down adjustments.

0 · Reply

Boston7452 Jun. 4 at 6:12 PM

$SINT Had news of Varian's investment in Ned Medical been made public back in January when it happened, Sintx wouldnt have had to do this recent BS offering. https://pitchbook.com/profiles/company/534753-37

0 · Reply

Boston7452 Jun. 4 at 3:45 PM

$SINT it’s time for investors to remove the c-suite and board, take back their shares, sue Ned Medical, and auction the billion tech to the highest bidders

1 · Reply

Boston7452 Jun. 4 at 3:14 PM

$SINT Varian Medical, Siemens oncology subsidiary, invested in Ned Medicals Series A round early this year. Ned raised 8m which should mean it had a valuation of 30-40m. That represents Ned Medicals half of this tech.

1 · Reply

Boston7452 Jun. 4 at 1:39 PM

$SINT I’m highly confident that thought Sintx mgmt initiated a lawsuit against their former CTO for theft of trade secrets , that this lawsuit is a ruse and their former CTO was given the OK to do this. Federal crime this is as the trade secrets crossed state borders.

0 · Reply

SnoopyDog Jun. 4 at 1:22 PM

$SINT so nothing changed and you now know who bought the offering and where the journey goes --> south

1 · Reply

SnoopyDog Jun. 4 at 1:21 PM

$SINT they are not being involved

1 · Reply

Brandon6161 Jun. 4 at 1:14 PM

$SINT Maxim initiated coverage of SINT with a buy rating, and a 12 month price target of $6. Current price $2.24. Current market cap of $14M. Let’s go!!

0 · Reply

Sintx Technologies resumed with a Buy at Maxim

Jun 3, 2026, 9:00 AM EDT - 1 day ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

May 17, 2026, 3:30 PM EDT - 18 days ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

2026-04-13T10:11:23.000Z - 7 weeks ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

Mar 23, 2026, 9:15 AM EDT - 2 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

2026-03-19T11:51:39.000Z - 2 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

Mar 19, 2026, 7:30 AM EDT - 2 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

2026-02-18T13:40:31.000Z - 3 months ago

Sintx Technologies appoints Elmore as President

Feb 18, 2026, 8:30 AM EST - 3 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Jan 29, 2026, 9:00 AM EST - 4 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

2025-12-01T13:35:45.000Z - 6 months ago

Sintx Technologies signs supply agreement with EVONIK

Dec 1, 2025, 8:30 AM EST - 6 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

2025-11-13T13:05:19.000Z - 7 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

2025-11-03T13:05:41.000Z - 7 months ago

Sintx Technologies announces launch of OsseoSculpt

Nov 3, 2025, 8:00 AM EST - 7 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

2025-10-23T20:40:36.000Z - 8 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-20T11:05:38.000Z - 8 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

Oct 20, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

2025-10-14T11:11:00.000Z - 8 months ago

Sintx Technologies announces U.S. patent notice of allowance

Oct 14, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

2025-09-30T20:55:10.000Z - 8 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-09T02:54:00.000Z - 9 months ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-08T12:01:04.000Z - 9 months ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

Sep 8, 2025, 7:54 AM EDT - 9 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

2025-09-08T11:25:37.000Z - 9 months ago

Sintx Technologies receives USPTO notice of allowance

Sep 8, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

2025-09-03T11:10:22.000Z - 9 months ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-08-15T11:11:47.000Z - 10 months ago

Sintx Technologies issues business update following strategic realignment

Aug 15, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

2025-08-04T11:20:10.000Z - 10 months ago

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

Aug 4, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

2025-07-22T11:10:59.000Z - 11 months ago

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

2025-06-24T12:40:21.000Z - 1 year ago

Sintx Technologies acquires SiNAPTIC surgical assets for $750,000 in shares

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

2TrustHim Jun. 5 at 4:43 AM

$SINT so when this all clears up where the price go

0 · Reply

Boston7452 Jun. 5 at 1:44 AM

0 · Reply

Boston7452 Jun. 4 at 8:06 PM

0 · Reply

Boston7452 Jun. 4 at 6:12 PM

0 · Reply

Boston7452 Jun. 4 at 3:45 PM

$SINT it’s time for investors to remove the c-suite and board, take back their shares, sue Ned Medical, and auction the billion tech to the highest bidders

1 · Reply

Boston7452 Jun. 4 at 3:14 PM

1 · Reply

Boston7452 Jun. 4 at 1:39 PM

0 · Reply

SnoopyDog Jun. 4 at 1:22 PM

$SINT so nothing changed and you now know who bought the offering and where the journey goes --> south

1 · Reply

SnoopyDog Jun. 4 at 1:21 PM

$SINT they are not being involved

1 · Reply

Brandon6161 Jun. 4 at 1:14 PM

$SINT Maxim initiated coverage of SINT with a buy rating, and a 12 month price target of $6. Current price $2.24. Current market cap of $14M. Let’s go!!

0 · Reply

Boston7452 Jun. 4 at 7:00 AM

$SINT regardless how corrupt mgmt is, the tech is still worth a mint and shareholder should remove them and auction the tech. Seems to be the only way to see a return on investment.

1 · Reply

Boston7452 Jun. 4 at 6:06 AM

$SINT from your perspective that seems true. However reality may play out differently especially if SEC & FBI get involved…we shall see. I did manage to get 60m write off so I won’t have to pay capital gains likely for the remainder of my life. Let’s see what else happens.

0 · Reply

SnoopyDog Jun. 4 at 5:54 AM

$SINT 5 years ago I warned you. No pot of gold at the end of the tunnel here. Just pure shareholder fraud and management cashing in big time.

1 · Reply

Boston7452 Jun. 4 at 1:07 AM

$SINT Medtech should be leading the way in a class action lawsuit against Sintx mgmt and board, sans Elmore, for as I believe, giving Ned Medical the know how to produce their own beads leading to this BS offering. Had they sold the manufacturing know how Sintx wouldn’t have needed to raise any funds.

1 · Reply

TheDragonsClaw Jun. 3 at 9:55 PM

$INDO $SINT $BATL $TPET

0 · Reply

Boston7452 Jun. 3 at 9:29 PM

$SINT looking like cost basis harvesting as the warrants price adjust on future offerings. Sec & FBI time!

0 · Reply

Boston7452 Jun. 3 at 4:00 PM

$SINT Depending on whom was on the receiving end of this offering will tell us alot about which direction this will go. If legit investors it should go up, if Ansons funds are a large participant likely means cost basis harvesting.

0 · Reply

Boston7452 Jun. 3 at 2:41 PM

$SINT what does this mean? “We are pleased to complete this financing and appreciate the strong support from well known Life Science investors”

1 · Reply

Boston7452 Jun. 3 at 2:21 PM

$SINT prolly cause of Honigblum who taught Sonny from the pre-ipo days.

0 · Reply

SnoopyDog Jun. 3 at 1:44 PM

$SINT nope

0 · Reply

SnoopyDog Jun. 3 at 1:44 PM

$SINT like said

0 · Reply

1BigWoody Jun. 3 at 1:42 PM

$SINT lol

0 · Reply

Market Cap	9.68M
Revenue (ttm)	1.02M
Net Income (ttm)	-10.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,015.69%
Debt to Equity Ratio	0.12

Volume	56,800
Avg Vol	49,456
Day's Range	N/A - N/A
Shares Out	4.32M
Stochastic %K	63%
Beta	0.66
Analysts	Sell
Price Target	$11.00